dr. nathan on long-term outcomes with dabrafenib/trametinib in braf v600-mutant melanoma
Published 4 years ago • 1.2K plays • Length 1:26Download video MP4
Download video MP3
Similar videos
-
1:46
dr. nathan on 5-year survival outcomes of combi-d and combi-v trials in braf v600-mutant melanoma
-
2:46
long-term outcomes with dabrafenib plus trametinib in braf v600-mutant melanoma
-
1:52
dr. long on dabrafenib/trametinib in braf v600e-mutant melanoma
-
2:19
dr. robert on 5-year analysis of dabrafenib/trametinib in braf v600-mutant melanoma
-
1:04
dr. wilson on long-term data with dabrafenib plus trametinib in melanoma
-
2:11
dr. georgina long on dabrafenib and trametinib in braf-mutated melanoma
-
1:31
dr. daud on dabrafenib/trametinib vs immunotherapy in melanoma
-
0:53
dabrafenib plus trametinib demonstrates benefit in braf-mutant melanoma
-
2:56
treating braf v600e-mutant nsclc with dabrafenib and trametinib
-
1:46
dr. long on the results of the pooled analysis of the combi-i trial in melanoma
-
0:30
dr. postow on fda approval of adjuvant dabrafenib plus trametinib in braf-mutant melanoma
-
2:51
combi-ad: long-term follow-up of dabrafenib and trametinib in braf-mutated melanoma
-
1:11
dr. weber on the fda approval of adjuvant dabrafenib/trametinib in braf-mutant melanoma
-
1:32
dr. flaherty on the rationale to explore triplet therapy in braf v600e-mutant melanoma
-
1:40
dr. robert on the phase iii combi-v study in braf-mutant melanoma
-
2:33
dr. sullivan discusses role of dabrafenib plus trametinib in melanoma
-
4:08
updates from combi-ad: dabrafenib and trametinib for melanoma
-
1:05
georgina long on treating melanoma with dabrafenib plus trametinib
-
0:44
dr. michael rotkowitz on dabrafenib and trametinib combination side effects